Thomas J. Moore, MD

Professor, Medicine

Thomas Moore
75 E. Newton St Evans Building


For almost two decades Thomas Moore, MD has investigated the development, sale, and prescription of drugs. He has investigated in depth how drugs are regulated and the system of determining a drug’s benefits and costs. In addition, He has spent many years involved in pharmaceutical litigation that arises from unsafe or improperly marketed drugs.

He is the current Associate Provost for the Boston University Medical Campus and a Professor of Medicine at Boston University School of Medicine.

Other Positions

  • Graduate Faculty (Primary Mentor of Grad Students), Boston University School of Medicine, Graduate Medical Sciences
  • Active Staff Privileges, Endocrinology, Diabetes & Nutrition, Medicine, Boston Medical Center


  • University of Cincinnati, MD
  • Xavier University, BA


  • Published on 11/18/2010

    Svetkey LP, Harris EL, Martin E, Vollmer WM, Meltesen GT, Ricchiuti V, Williams G, Appel LJ, Bray GA, Moore TJ, Winn MP, Conlin PR. Modulation of the BP response to diet by genes in the renin-angiotensin system and the adrenergic nervous system. Am J Hypertens. 2011 Feb; 24(2):209-17. PMID: 21088669.

    Read at: PubMed
  • Published on 7/1/2010

    Rosenzweig JL, Taitel MS, Norman GK, Moore TJ, Turenne W, Tang P. Diabetes disease management in Medicare Advantage reduces hospitalizations and costs. Am J Manag Care. 2010 Jul; 16(7):e157-62. PMID: 20645661.

    Read at: PubMed
  • Published on 10/23/2009

    Sacks N, Cabral H, Kazis LE, Jarrett KM, Vetter D, Richmond R, Moore TJ. A web-based nutrition program reduces health care costs in employees with cardiac risk factors: before and after cost analysis. J Med Internet Res. 2009; 11(4):e43. PMID: 19861297.

    Read at: PubMed
  • Published on 1/23/2009

    Jacobs DR, Gross MD, Steffen L, Steffes MW, Yu X, Svetkey LP, Appel LJ, Vollmer WM, Bray GA, Moore T, Conlin PR, Sacks F. The effects of dietary patterns on urinary albumin excretion: results of the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Kidney Dis. 2009 Apr; 53(4):638-46. PMID: 19167797.

    Read at: PubMed
  • Published on 12/12/2008

    Moore TJ, Alsabeeh N, Apovian CM, Murphy MC, Coffman GA, Cullum-Dugan D, Jenkins M, Cabral H. Weight, blood pressure, and dietary benefits after 12 months of a Web-based Nutrition Education Program (DASH for health): longitudinal observational study. J Med Internet Res. 2008; 10(4):e52. PMID: 19073541.

    Read at: PubMed
  • Published on 1/1/2006

    Moore TJ. Arterial hypertension and hypertensive encephalopathy. In Neurological Therapeutics Principles and Practice 2nd Edition. JH Noseworthy (editor-in-chief). Martin Dunitz Press. London. 2006.

  • Published on 1/1/2005

    Vollmer WM, Appel LJ, Svetkey LP, Moore TJ, Vogt TM, Conlin PR, Proschan M, Harsha D. Comparing office-based and ambulatory blood pressure monitoring in clinical trials. J Hum Hypertens. 2005 Jan; 19(1):77-82. PMID: 15361888.

    Read at: PubMed
  • Published on 7/1/2004

    Svetkey LP, Simons-Morton DG, Proschan MA, Sacks FM, Conlin PR, Harsha D, Moore TJ. Effect of the dietary approaches to stop hypertension diet and reduced sodium intake on blood pressure control. J Clin Hypertens (Greenwich). 2004 Jul; 6(7):373-81. PMID: 15249792.

    Read at: PubMed
  • Published on 7/1/2004

    Moore TJ. The DASH Diet in the Control of Hypertension. Current Opinion in Endocrinology & Diabetes. 2004.

  • Published on 9/2/2003

    Obarzanek E, Proschan MA, Vollmer WM, Moore TJ, Sacks FM, Appel LJ, Svetkey LP, Most-Windhauser MM, Cutler JA. Individual blood pressure responses to changes in salt intake: results from the DASH-Sodium trial. Hypertension. 2003 Oct; 42(4):459-67. PMID: 12953018.

    Read at: PubMed

View 98 more publications: View full profile at BUMC

View all profiles